Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis

Advances in Experimental Medicine and Biology

Volumn 470, Issue , 2000, Pages 45-53

  Stoner, G D ^a,b,c   Budd, G T ^d   Ganapathi, R ^d   DeYoung, B ^c   Kresty, L A ^a   Nitert, M ^a   Fryer, B ^e   Church, J M ^d   Provencher, K ^d   Pamukcu, R ^e   Piazza, G ^e   Hawk, E ^f   Kelloff, G ^f   Elson, P ^e   Van Stolk, R U ^d  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c Department of Pathology ^*  (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e Cell Pathways Inc   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; KI 67 ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC SULFONE;

ADENOMATOUS POLYP; AMINOTRANSFERASE BLOOD LEVEL; CELL PROLIFERATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; HUMAN; IMMUNOPHENOTYPING; LABELING INDEX; LIVER TOXICITY; PRIORITY JOURNAL; RECTUM POLYP; TUMOR VOLUME;

ADENOMATOUS POLYPOSIS COLI; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KI-67 ANTIGEN; SULINDAC; TUMOR MARKERS, BIOLOGICAL;

EID: 0034469062     PISSN: 00652598     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. The rectum in adenomatous polyposis: The St. Mark's policy
2. The genetic and molecular diagnosis of adenomatous polyposis coli
3. Altered eicosanoid levels in human colon cancer
4. Sulindac for polyposis of the colon
5. Effects of long-term sulindac therapy on colonic polyposis
6. Sulindac causes regression of rectal polyps in familial adenomatous polyposis
7. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
8. A protective effect of sulindac against chemically-induced primary colonic tumors in mice
9. Sulindac inhibits the rate of growth and appearance of colon tumors in the rat
10. Prostaglandin synthetase inhibitors
11. Chemical and biological studies of indomethacin, sulindac, and their analogs
12. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis
13. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels
14. Safety and tolerability of sulindac sulfone (Exisulind) in patients with familial adenomatous polyposis, results of a phase I and pharmacokinetic trial
15. Monoclonal antibodies against recombinant parts of the ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed sections
16. Identification of prolonged cell death in situ via specific labeling of nuclear DNA fragmentation
17. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction